Dasamaps 70 (Dasatinib (70mg))

Dasamaps 70 Tablet contains Dasatinib as its active ingredient and is primarily used for managing certain types of blood cancers, specifically chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). It supports patients by targeting specific cells involved in these conditions, helping to slow down or stop their growth.

Dasatinib works by inhibiting certain proteins that promote cancer cell proliferation. By blocking these proteins, Dasamaps helps to disrupt the cancerous process in the body, aiming to improve the quality of life for those affected by these serious conditions.

For optimal results, it’s important to store Dasamaps 70 Tablet in a cool, dry place away from direct sunlight and moisture. Consistency in usage is key, so following a regular schedule as advised by a healthcare professional can be beneficial. Patients should also be cautious and inform their doctor about any existing medical conditions or medications they are taking to avoid potential interactions or complications.

Common mild side effects of Dasamaps may include fatigue, nausea, headache, and skin rash. While these effects can be bothersome, they are typically manageable. If any side effects persist or worsen, it’s advisable to consult a healthcare provider.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.